Price range: $198.00 through $282.00
Research-Grade GLP-1S (glucagon-like peptide-1) is a naturally occurring hormone that plays a key role in blood sugar control and appetite regulation. It is released by the gut after eating and helps lower blood glucose levels by stimulating insulin secretion, reducing glucagon release, slowing gastric emptying and promoting fullness.
This GLP 1 peptides contains about 6mg to 10mg of the dosage, with a multi-pen of total dosage in a multi-dose pen.
Oral Convenience: Eli Lilly is developing orforglipron, a non-oral GLP-1 Peptide which bypasses the need for injection.
Efficacy Trials: Various trials investigate its efficiency in weight management. The research shows that about 6mg of the dosage, in which there are great chances of weight loss, with doses showing 11.2% of weight loss in 72 weeks.
Cardiovascular Outcomes (CVOTs): Various ongoing trials, like SOUL, investigate how it has reduced the number of strokes and heart attacks, leading to very few cardiovascular deaths. Especially in patients with chronic kidney disease.
Heart Failure with Preserved Ejection Fraction (HFpEF): The research, such as STEP and HFPEF, shows that about 2.4 mg of semaglutide improves the physical function of weight loss in patients with obesity.
Various drugs stimulate the pancreatic beta cells, especially when there are higher blood sugar levels, which results in postprandial after-meal with reduced risk of hypoglycemia.
This decreases the release of glucagon from the pancreatic alpha cells, as it prevents the liver from releasing glucose in the bloodstream, and as a result, it prevents sugar spikes.
The GLP-1Rs can act as the brain’s satiety centre (in the hypothalamus), and they reduce hunger, fullness, and food cravings.
These agents slow down the rate at which food leaves the stomach, resulting in the prolonged sensation of fullness and decreased speed of glucose absorption.
It’s still investigating the causes to sustain weight loss even after one or two years and manage the weight regain once the treatment is discontinued.
We can address the loss of lean mass (sarcopenia) with fat loss and develop strategies for managing muscle preservation.
MASLD/MASH: Various things can evaluate the high dosages of GLP-1s on the metabolic dysfunction associated with steatotic liver disease. With key studies focused on fibrosis reversal.
Neurodegenerative Diseases: Ongoing clinical trials can investigate the neuroprotective effects of GLP-1 in Parkinson’s and alzheimer’s diseases. They can likely go through reduced neuroinflammation with improved glucose metabolism.
Note : Please review and adhere to our Terms and Conditions before ordering
Sequence:His-Ala-Glu-Gly-Ser-Gly-Ser-Glu-Ser-Glu-Gln-Ser-Glu-Ala-Leu-Asp-Gln-Glu-Gly-Gly-Arg-Glu-Gln-Asp-Leu-Ser-Phe-Glu-Glu-Tyr-Gln-His
Molecular Formula: C187H291N45O59
Molecular Weight: ~ 4113 Da
Tesamorelin(10mg) is a synthetic growth hormone-releasing hormone (GHRH) analog developed to stimulate endogenous growth hormone (GH) secretion. It is FDA-approved for reducing excess abdominal (visceral) fat in patients with HIV-associated lipodystrophy. By increasing GH and IGF-1 levels, Tesamorelin promotes lipolysis while preserving lean body mass. It is also being investigated for broader metabolic and fat-reduction benefits, including potential applications in non-HIV-related obesity and non-alcoholic fatty liver disease (NAFLD).
| Quantity | 10mg |
|---|
SS-31 peptide is a mitochondria-targeted synthetic peptide from the Szeto-Schiller (SS) family, designed to protect and restore mitochondrial function. It selectively accumulates in the inner mitochondrial membrane (IMM), stabilizes cardiolipin, reduces oxidative stress, and enhances ATP production. SS-31 has been widely studied for its therapeutic potential in neurodegenerative, cardiovascular, metabolic, and renal conditions in which mitochondrial dysfunction is a core feature.
| Quantity | 25mg |
|---|
NAD⁺ (Nicotinamide Adenine Dinucleotide) is a vital coenzyme present in all living cells, critical to energy metabolism, DNA repair, mitochondrial function, and cellular signalling. It exists in oxidized (NAD⁺) and reduced (NADH) forms and plays a central role in ageing, neurodegeneration, immunity, and metabolic health. As NAD⁺ levels decline with age, supplementation strategies (e.g., NMN, NR) are being explored to enhance healthspan and lifespan.
| Quantity | 1000mg |
|---|
Melanotan 2 is a synthetic melanocortin peptide known for stimulating melanin production in the skin, leading to enhanced tanning with minimal sun exposure. It also exhibits secondary effects such as increased libido, appetite suppression, and fat metabolism. Due to its interaction with multiple melanocortin receptors, MT2 has therapeutic potential for erectile dysfunction, skin protection, and metabolic regulation.
| Quantity | 10mg |
|---|
